These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 29698559

  • 1. Tuftsin-phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model.
    Shemer A, Kivity S, Shovman O, Bashi T, Perry O, Watad A, Ben-Ami Shor D, Volkov A, Barshack I, Bragazzi NL, Krule A, Fridkin M, Amital H, Blank M, Shoenfeld Y.
    Clin Exp Immunol; 2018 Aug; 193(2):160-166. PubMed ID: 29698559
    [Abstract] [Full Text] [Related]

  • 2. Successful modulation of murine lupus nephritis with tuftsin-phosphorylcholine.
    Bashi T, Blank M, Ben-Ami Shor D, Fridkin M, Versini M, Gendelman O, Volkov A, Barshak I, Shoenfeld Y.
    J Autoimmun; 2015 May; 59():1-7. PubMed ID: 25864802
    [Abstract] [Full Text] [Related]

  • 3. Helminths-based bi-functional molecule, tuftsin-phosphorylcholine (TPC), ameliorates an established murine arthritis.
    Blank M, Bashi T, Lachnish J, Ben-Ami-Shor D, Shovman O, Fridkin M, Eisenstein M, Volkov A, Barshack I, Shoenfeld Y.
    PLoS One; 2018 May; 13(8):e0200615. PubMed ID: 30089122
    [Abstract] [Full Text] [Related]

  • 4. Tuftsin phosphorylcholine-a novel compound harnessing helminths to fight autoimmunity.
    Segal Y, Blank M, Shoenfeld Y.
    Immunol Res; 2018 Dec; 66(6):637-641. PubMed ID: 30554380
    [Abstract] [Full Text] [Related]

  • 5. The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis.
    Croci S, Bonacini M, Muratore F, Caruso A, Fontana A, Boiardi L, Soriano A, Cavazza A, Cimino L, Belloni L, Perry O, Fridkin M, Parmeggiani M, Blank M, Shoenfeld Y, Salvarani C.
    J Autoimmun; 2019 Mar; 98():113-121. PubMed ID: 30638709
    [Abstract] [Full Text] [Related]

  • 6. Novel therapeutic compound tuftsin-phosphorylcholine attenuates collagen-induced arthritis.
    Bashi T, Shovman O, Fridkin M, Volkov A, Barshack I, Blank M, Shoenfeld Y.
    Clin Exp Immunol; 2016 Apr; 184(1):19-28. PubMed ID: 26618631
    [Abstract] [Full Text] [Related]

  • 7. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.
    Nozaki Y, Yamagata T, Yoo BS, Sugiyama M, Ikoma S, Kinoshita K, Funauchi M, Kanamaru A.
    Clin Exp Immunol; 2005 Jan; 139(1):74-83. PubMed ID: 15606616
    [Abstract] [Full Text] [Related]

  • 8. Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis.
    Novikova NS, Diatlova AS, Derevtsova KZ, Korneva EA, Viktorovna TV, Ostrinki Y, Abraham L, Quinn S, Segal Y, Churilov LP, Blank M, Shoenfeld Y, Aharoni R, Amital H.
    J Neuroimmunol; 2019 Dec 15; 337():577070. PubMed ID: 31683117
    [Abstract] [Full Text] [Related]

  • 9. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W, Zheng H, Wu S, Zhang Y, Wang W, Zhang Z, Zhou C, Wu H, Min J.
    Am J Nephrol; 2017 Dec 15; 46(5):371-379. PubMed ID: 29069649
    [Abstract] [Full Text] [Related]

  • 10. HSPB5 suppresses renal inflammation and protects lupus-prone NZB/W F1 mice from severe renal damage.
    Knapp J, Braunstein M, Berg SIT, Shirriff C.
    Arthritis Res Ther; 2022 Dec 12; 24(1):267. PubMed ID: 36510250
    [Abstract] [Full Text] [Related]

  • 11. Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.
    Li X, Wang M, Hong H, Luo C, Liu Z, Yang R.
    Immunol Res; 2018 Aug 12; 66(4):521-527. PubMed ID: 30047025
    [Abstract] [Full Text] [Related]

  • 12. Curcumin attenuates murine lupus via inhibiting NLRP3 inflammasome.
    Zhao J, Wang J, Zhou M, Li M, Li M, Tan H.
    Int Immunopharmacol; 2019 Apr 12; 69():213-216. PubMed ID: 30738291
    [Abstract] [Full Text] [Related]

  • 13. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P, Langnickel D, Riemekasten G.
    Scand J Rheumatol; 2006 Apr 12; 35(3):209-16. PubMed ID: 16766368
    [Abstract] [Full Text] [Related]

  • 14. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.
    Ann Rheum Dis; 2008 Feb 12; 67(2):154-61. PubMed ID: 17557887
    [Abstract] [Full Text] [Related]

  • 15. Intranuclear delivery of the transcription modulation domain of Tbet-improved lupus nephritis in (NZB/NZW) F1 lupus-prone mice.
    Moon JS, Mun CH, Kim JH, Cho JY, Park SD, Park TY, Shin JS, Ho CC, Park YB, Ghosh S, Bothwell ALM, Lee SW, Lee SK.
    Kidney Int; 2018 May 12; 93(5):1118-1130. PubMed ID: 29409726
    [Abstract] [Full Text] [Related]

  • 16. Infusion of anti-DFS70 antibodies prolonged survival of lupus-prone mice.
    Aljadeff G, Shemer A, Katz I, Andrade LEC, Gilburd B, Halpert G, Mahler M, Blank M, Amital H, Shoenfeld Y.
    Lupus; 2021 Feb 12; 30(2):320-324. PubMed ID: 33175665
    [Abstract] [Full Text] [Related]

  • 17. Phosphorylcholine-tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: implications for the treatment of human inflammatory bowel disease.
    Ben-Ami Shor D, Bashi T, Lachnish J, Fridkin M, Bizzaro G, Barshak I, Blank M, Shoenfeld Y.
    J Autoimmun; 2015 Jan 12; 56():111-7. PubMed ID: 25479760
    [Abstract] [Full Text] [Related]

  • 18. Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB/NZW) F1 mice.
    Mun CH, Kim JO, Ahn SS, Yoon T, Kim SJ, Ko E, Noh HD, Park YB, Jung HJ, Kim TS, Lee SW, Park SG.
    Biomaterials; 2019 Nov 12; 220():119408. PubMed ID: 31394431
    [Abstract] [Full Text] [Related]

  • 19. Low-Molecular-Weight Heparin Enhanced Therapeutic Effects of Human Adipose-Derived Stem Cell Administration in a Mouse Model of Lupus Nephritis.
    Matsuda S, Kotani T, Saito T, Suzuka T, Mori T, Takeuchi T.
    Front Immunol; 2021 Nov 12; 12():792739. PubMed ID: 35095868
    [Abstract] [Full Text] [Related]

  • 20. Helminth derivative tuftsin-phopshorylcholine to treat autoimmunity.
    Blank M, Shoenfeld Y.
    Autoimmun Rev; 2024 Oct 12; 23(10):103601. PubMed ID: 39159711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.